This study was published in Drug Safety 2008;31(5):399-407
Study title and authors:
Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.
Study title and authors:
Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.
Becker C, Jick SS, Meier CR.
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/18422380
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/18422380
This study set out to explore the risk of the development of Parkinson's disease in people with untreated high cholesterol and with people treated with statins and fibrates. 3,637 people with Parkinson's were compared with the same number of controls.
The study found:
(a) Those people with high cholesterol who did not take statins had a 2% lower risk of Parkinson's compared to those with lower cholesterol.
(b) Those who took statins had a 6% higher risk of Parkinson's.
(c) Those who took fibrates had a 25% higher risk of Parkinson's.
The results of this study show that statins and fibrates increase the risk of Parkinson's.
Links to other studies:
Possible link with statins and dementia
Statins implicated in multiple sclerosis
Statins may be implicated in neurodegenerative diseases
